Differential capacity of CD90+ cells in autophagy activation following chemotherapy in hepatocellular carcinoma.
CONCLUSIONS: We demonstrated the relevance of differential autophagy capacity of CD90+ cells in HCC. Autophagy was involved in cancer-defense mechanism against doxorubicin. Cancer promoting function of autophagy in CD90+ cells was also related to cancer environment.
PMID: 32745631 [PubMed - as supplied by publisher]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Environmental Health | Gastroenterology | Genetics | Hepatocellular Carcinoma | Liver | Liver Cancer | Stem Cell Therapy | Stem Cells | Study | Toxicology | Urology & Nephrology